"Solution" first, then Problem, except, its not really a "Solution" it's merely future stock guarantees.
Member, mRNA was already ready before muh covid…
Agree to disagree… they always have the fake solution in the wings first. Pretending they don't, so the panic & fear porn builds, until people are begging for help, then they swoop in with the fake solution.
Why did Gates and Darpa give grants to Moderna
DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics™
October 2, 2013 at 9:00 AM EDT
PDF Version
Research to focus on antibody production for immune defense
https://investors.modernatx.com/news-releases/news-release-details/darpa-awards-moderna-therapeutics-grant-25-million-develop
Look back.
>Melle Stewart
Think the "Warp Speed" thing was really about the treatments with the Plasma and blood shit people were donating when they got Covid. Trump made an point of calling attention to PLASMA and being asked to donate blood.
"After being admitted to the neurological ICU, Melle was formally diagnosed with Vaccine-Induced Thrombocytopenic Thrombosis (VITT). This is the extremely rare condition you may have heard or read about in the news, a condition that is now acknowledged by the manufacturer and the regulators as a very rare side effect of this particular vaccine. Unfortunately, Melle had had a severe stroke, caused by two large clots in the main veins of her brain, with the pressure and low platelets causing a secondary bleed in the left frontal lobe. Melle spent 3 weeks in an induced coma during which time she was ventilated andreceived a number of blood transfusion procedures to help remove the antibodies created by the vaccine that were causing the clots.She was also put on heavy doses of anti-clotting and anti-seizure medication, which continue to this day."
more
https://www.gofundme.com/f/help-melle-stewart-after-lifethreatening-stroke
How about they call to END THE NIH?
Not just name a new director. That's continuing the insanity. NIH is just one part of the Snake.
Capitol Hill drug pricing reform opponents among the biggest beneficiaries of pharma funds
(Reuters) - Democratic Party lawmakers holding up proposed drug pricing reforms are among the largest beneficiaries of the pharmaceutical industry's push to stave off price cuts, a Reuters analysis of public lobbying and campaign data shows.
The industry, which traditionally gives more to Republicans, channeled around 60% of donated campaign funds to Democrats this year. It has spent over $177 million on lobbying and campaign donations in 2021.
Nonprofit political action committees (PACs) run by Pfizer Inc and Amgen Inc and the Pharmaceutical Research and Manufacturers of America (PhRMA) were among the biggest donors, according to political spending data from OpenSecrets, formerly the Center for Responsive Politics.
Drugmakers are seeking to block laws that would give the U.S. government authority to negotiate prices for prescription medicines. Current U.S. law bars the government's Medicare health insurance program from negotiating drug prices directly.
Many of the Democrats opposing an ambitious drug reduction bill proposed in the House of Representatives are among some of the biggest recipients of drug manufacturer lobbying funds.
They include Senators Kyrsten Sinema of Arizona, Robert Menendez of New Jersey, and Representative Scott Peters of California, OpenSecrets data covering industry donations through September of 2021 shows. In all, they have received around $1 million in pharmaceutical and health product industry donations this year.
A spokesperson for Sinema did not respond to a request for comment on the funds she has received but said the Senator supports making drugs as cheap as possible for patients.
Menendez and Peters said the donations did not influence their views. All three said they are opposed to The Lower Drug Costs Now Act, which is sponsored by Democrats in the House of Representatives and also known as H.R.3.
Menendez and Peters have advocated for alternative scaled-back drug pricing reforms that would still allow Medicare to negotiate drug prices but would lead to significantly smaller savings.
Congressman Frank Pallone of New Jersey, who is also one of the top recipients of drugmaker donations, voted in favor of H.R.3.
Sinema, who campaigned in 2018 on cutting drug prices, told the White House she opposes allowing Medicare to negotiate them. She received about $466,000 from the industry in 2021, according to OpenSecrets data.
Peters was the top recipient of pharmaceutical industry funds in the House this year at nearly $99,550, according to OpenSecrets data. A spokesperson said Peters was not influenced by lobbying money and opposed the proposed law to protect pharmaceutical industry jobs and innovation.
Drugmakers say the Democrats’ proposed drug price overhaul would undermine their ability to develop new medicines, an argument they have used whenever price cuts are discussed by politicians regardless of political party.
"Patients face a future with less hope under Congress' current drug pricing plan," PhRMA Chief Executive Steve Ubl said in an August statement in reference to the proposed law. PhRMA declined to comment on donating to key Democratic opponents of the bill.
The United States is an outlier as most other developed nations do negotiate drug prices with manufacturers.
Amgen did not immediately respond to requests for comment on its donations and Pfizer declined to comment.
more
https://www.yahoo.com/finance/news/capitol-hill-drug-pricing-reform-110513269.html